Pelthos Therapeutics Inc. PTHS Income Statement
| FY'25 | FY'24 | FY'23 | ||
|---|---|---|---|---|
| $16.8M— | $0— | —— | ||
| $3.99M— | $0— | —— | ||
| $12.81M— | $0— | —— | ||
| 76.3%— | —— | —— | ||
| $1.23M+4.1% | $1.18M-54.3% | $2.58M+558% | ||
| $42.45M— | —— | —— | ||
| —— | $7.57M— | —— | ||
| -$32.43M-328% | -$7.57M-10.3% | -$6.86M-196% | ||
| -193.1%— | —— | —— | ||
| $3.01M— | —— | —— | ||
| $5K-98.8% | $402K— | —— | ||
| -$18.28M-4,661% | -$383.88K+26.0% | -$518.51K-269% | ||
| -$50.71M-537% | -$7.95M-7.8% | -$7.38M-200% | ||
| -$7.39M— | $0— | —— | ||
| -$43.32M-445% | -$7.96M-7.8% | -$7.38M-200% | ||
| -257.9%— | —— | —— | ||
| —— | -$14.27-147% | -$5.78— | ||
| —— | -$14.31-348% | $5.76+1.9% | ||
| —— | —— | —— | ||
| —— | 16.8M+284% | 4.4M— | ||
| $1.56M— | $0— | —— | ||
| —— | $0— | —— | ||
| —— | -$7.96M— | —— | ||
| $285K— | $0— | —— | ||
| $5K-98.8% | $402K— | —— | ||
| $16.8M— | $0— | —— | ||
| -$32.43M-328% | -$7.57M-10.3% | -$6.86M-196% | ||
| -$30.53M-303% | -$7.57M— | —— | ||
| -$30.53M-303% | -$7.57M— | —— | ||
| -181.8%— | —— | —— | ||
| -$32.43M-328% | -$7.57M-10.3% | -$6.86M-196% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Pelthos Therapeutics Inc.'s revenue?
- Pelthos Therapeutics Inc. (PTHS) generated $27.7M in revenue over the trailing twelve months.
- Is Pelthos Therapeutics Inc. profitable?
- Pelthos Therapeutics Inc. is not currently profitable: it reported a net loss of $51.6M over the trailing twelve months, a -186.2% net margin.
- What are Pelthos Therapeutics Inc.'s profit margins?
- Gross margin is 79.6% and operating margin is -157.7%, with a -186.2% net margin.
- What is Pelthos Therapeutics Inc.'s earnings per share?
- Pelthos Therapeutics Inc.'s diluted EPS over the trailing twelve months is $-13.44.
- Where does Pelthos Therapeutics Inc.'s income statement data come from?
- Every line is extracted from Pelthos Therapeutics Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
